Crizotinib

Crizotinib, sold under the brand name Xalkori among others, is an anti-cancer medication acting as an ALK (anaplastic lymphoma kinase) and ROS1 (c-ros oncogene 1) inhibitor,[3][4][5] approved for treatment of some non-small cell lung carcinoma (NSCLC) in the US[6] and some other countries, and undergoing clinical trials testing its safety and efficacy in anaplastic large cell lymphoma, neuroblastoma, and other advanced solid tumo... [wikipedia]